Structure

Physi-Chem Properties

Molecular Weight:  286.11
Volume:  275.834
LogP:  -0.579
LogD:  -0.278
LogS:  -0.942
# Rotatable Bonds:  7
TPSA:  127.45
# H-Bond Aceptor:  7
# H-Bond Donor:  5
# Rings:  1
# Heavy Atoms:  7

MedChem Properties

QED Drug-Likeness Score:  0.467
Synthetic Accessibility Score:  3.36
Fsp3:  0.462
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -6.051
MDCK Permeability:  0.007850416004657745
Pgp-inhibitor:  0.0
Pgp-substrate:  0.005
Human Intestinal Absorption (HIA):  0.867
20% Bioavailability (F20%):  0.356
30% Bioavailability (F30%):  0.985

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.919
Plasma Protein Binding (PPB):  12.84471321105957%
Volume Distribution (VD):  0.476
Pgp-substrate:  69.14775848388672%

ADMET: Metabolism

CYP1A2-inhibitor:  0.024
CYP1A2-substrate:  0.091
CYP2C19-inhibitor:  0.01
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.002
CYP2C9-substrate:  0.215
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.17
CYP3A4-inhibitor:  0.017
CYP3A4-substrate:  0.037

ADMET: Excretion

Clearance (CL):  6.353
Half-life (T1/2):  0.923

ADMET: Toxicity

hERG Blockers:  0.02
Human Hepatotoxicity (H-HT):  0.388
Drug-inuced Liver Injury (DILI):  0.118
AMES Toxicity:  0.007
Rat Oral Acute Toxicity:  0.03
Maximum Recommended Daily Dose:  0.007
Skin Sensitization:  0.067
Carcinogencity:  0.014
Eye Corrosion:  0.003
Eye Irritation:  0.157
Respiratory Toxicity:  0.015

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470989

Natural Product ID:  NPC470989
Common Name*:   3-[1-[3-Acetyl-2,4,6-Trihydroxy-5-(3-Methylbut-2-Enyl)Phenyl]-2-Oxoheptyl]-5-Ethyl-4-Hydroxy-6-Methylpyran-2-One
IUPAC Name:   3-[1-[3-acetyl-2,4,6-trihydroxy-5-(3-methylbut-2-enyl)phenyl]-2-oxoheptyl]-5-ethyl-4-hydroxy-6-methylpyran-2-one
Synonyms:  
Standard InCHIKey:  MLHCHYFNKPHMMY-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C28H36O8/c1-7-9-10-11-19(30)21(23-24(31)17(8-2)16(6)36-28(23)35)22-26(33)18(13-12-14(3)4)25(32)20(15(5)29)27(22)34/h12,21,31-34H,7-11,13H2,1-6H3
SMILES:  CCCCCC(=O)C(c1c(=O)oc(c(c1O)CC)C)c1c(O)c(CC=C(C)C)c(c(c1O)C(=O)C)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2334821
PubChem CID:   71717009
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0004603] Organic oxygen compounds
      • [CHEMONTID:0000323] Organooxygen compounds
        • [CHEMONTID:0001831] Carbonyl compounds
          • [CHEMONTID:0000118] Ketones
            • [CHEMONTID:0003670] Aryl ketones
              • [CHEMONTID:0004296] Phenylketones
                • [CHEMONTID:0004298] Alkyl-phenylketones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO25148.1 Helichrysum italicum Under-species n.a. n.a. Flowered aerial parts Arzana, Sardinia 2010-Jul PMID[23265253]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 8.0 ug.mL-1 PMID[455126]
NPT16 Organism Staphylococcus aureus Staphylococcus aureus MIC = 16.0 ug.mL-1 PMID[455126]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470989 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC470985
0.9769 High Similarity NPC470984
0.9692 High Similarity NPC470988
0.9615 High Similarity NPC185624
0.9462 High Similarity NPC21378
0.9462 High Similarity NPC470987
0.9338 High Similarity NPC470986
0.9197 High Similarity NPC19476
0.9197 High Similarity NPC241975
0.9124 High Similarity NPC219584
0.9124 High Similarity NPC199458
0.9124 High Similarity NPC470083
0.9124 High Similarity NPC183639
0.9051 High Similarity NPC474624
0.9051 High Similarity NPC138047
0.9051 High Similarity NPC131782
0.8936 High Similarity NPC307895
0.8936 High Similarity NPC470553
0.8913 High Similarity NPC322301
0.8913 High Similarity NPC255801
0.8873 High Similarity NPC288910
0.8873 High Similarity NPC470554
0.8873 High Similarity NPC118059
0.8873 High Similarity NPC133060
0.8865 High Similarity NPC470556
0.8865 High Similarity NPC112829
0.8811 High Similarity NPC181388
0.8811 High Similarity NPC470910
0.8803 High Similarity NPC474939
0.8803 High Similarity NPC470909
0.8803 High Similarity NPC96216
0.8803 High Similarity NPC184738
0.8803 High Similarity NPC33653
0.8794 High Similarity NPC470555
0.8786 High Similarity NPC472343
0.8768 High Similarity NPC50455
0.8759 High Similarity NPC16197
0.8741 High Similarity NPC469935
0.8741 High Similarity NPC178627
0.8741 High Similarity NPC1886
0.8741 High Similarity NPC196137
0.8732 High Similarity NPC472344
0.8732 High Similarity NPC294432
0.8731 High Similarity NPC470981
0.8723 High Similarity NPC477272
0.8723 High Similarity NPC221173
0.8705 High Similarity NPC470983
0.8705 High Similarity NPC470982
0.8705 High Similarity NPC194579
0.8686 High Similarity NPC285054
0.8686 High Similarity NPC15834
0.8686 High Similarity NPC215875
0.8681 High Similarity NPC154217
0.8681 High Similarity NPC470322
0.8671 High Similarity NPC87609
0.8671 High Similarity NPC188632
0.8671 High Similarity NPC470296
0.8671 High Similarity NPC112791
0.8671 High Similarity NPC196459
0.8671 High Similarity NPC94794
0.8662 High Similarity NPC476508
0.8633 High Similarity NPC474726
0.8633 High Similarity NPC101752
0.8633 High Similarity NPC475955
0.863 High Similarity NPC469932
0.8623 High Similarity NPC175943
0.8621 High Similarity NPC177995
0.8621 High Similarity NPC474108
0.8611 High Similarity NPC71184
0.8611 High Similarity NPC206212
0.8601 High Similarity NPC36181
0.8592 High Similarity NPC472603
0.8582 High Similarity NPC470669
0.8582 High Similarity NPC474487
0.8582 High Similarity NPC470671
0.8582 High Similarity NPC470672
0.8582 High Similarity NPC131130
0.8582 High Similarity NPC474504
0.8582 High Similarity NPC328983
0.8582 High Similarity NPC470668
0.8571 High Similarity NPC321387
0.8571 High Similarity NPC327059
0.8571 High Similarity NPC158866
0.8571 High Similarity NPC174999
0.8562 High Similarity NPC469933
0.8562 High Similarity NPC208303
0.8562 High Similarity NPC161864
0.8552 High Similarity NPC25844
0.854 High Similarity NPC279566
0.8531 High Similarity NPC316560
0.8531 High Similarity NPC316911
0.8531 High Similarity NPC111201
0.8521 High Similarity NPC472601
0.8521 High Similarity NPC472600
0.8521 High Similarity NPC240305
0.8521 High Similarity NPC275903
0.8521 High Similarity NPC477956
0.8519 High Similarity NPC329205
0.8519 High Similarity NPC316625
0.8511 High Similarity NPC191835
0.8507 High Similarity NPC475733
0.8496 Intermediate Similarity NPC472029
0.8496 Intermediate Similarity NPC65761
0.8493 Intermediate Similarity NPC297886
0.8493 Intermediate Similarity NPC249942
0.8493 Intermediate Similarity NPC285748
0.8493 Intermediate Similarity NPC140120
0.8489 Intermediate Similarity NPC108113
0.8489 Intermediate Similarity NPC93756
0.8483 Intermediate Similarity NPC469953
0.8483 Intermediate Similarity NPC75694
0.8478 Intermediate Similarity NPC27490
0.8477 Intermediate Similarity NPC263483
0.8472 Intermediate Similarity NPC297600
0.8472 Intermediate Similarity NPC321148
0.8472 Intermediate Similarity NPC321629
0.8472 Intermediate Similarity NPC472006
0.8472 Intermediate Similarity NPC478202
0.8472 Intermediate Similarity NPC323884
0.8472 Intermediate Similarity NPC326193
0.8472 Intermediate Similarity NPC159721
0.8467 Intermediate Similarity NPC469934
0.8467 Intermediate Similarity NPC186628
0.8462 Intermediate Similarity NPC307990
0.8462 Intermediate Similarity NPC158634
0.8462 Intermediate Similarity NPC16455
0.8462 Intermediate Similarity NPC253822
0.8462 Intermediate Similarity NPC82920
0.8462 Intermediate Similarity NPC472605
0.8462 Intermediate Similarity NPC164697
0.8462 Intermediate Similarity NPC472604
0.8462 Intermediate Similarity NPC471587
0.8462 Intermediate Similarity NPC289660
0.8451 Intermediate Similarity NPC32360
0.8451 Intermediate Similarity NPC54820
0.8451 Intermediate Similarity NPC112789
0.8451 Intermediate Similarity NPC88269
0.8451 Intermediate Similarity NPC477056
0.8451 Intermediate Similarity NPC272844
0.8451 Intermediate Similarity NPC19622
0.8451 Intermediate Similarity NPC477055
0.8451 Intermediate Similarity NPC180501
0.8451 Intermediate Similarity NPC254168
0.8451 Intermediate Similarity NPC268178
0.8451 Intermediate Similarity NPC248995
0.8451 Intermediate Similarity NPC268052
0.8446 Intermediate Similarity NPC470908
0.8446 Intermediate Similarity NPC474735
0.844 Intermediate Similarity NPC156910
0.844 Intermediate Similarity NPC70380
0.844 Intermediate Similarity NPC71256
0.8435 Intermediate Similarity NPC145467
0.8435 Intermediate Similarity NPC37139
0.8435 Intermediate Similarity NPC472345
0.8429 Intermediate Similarity NPC125920
0.8429 Intermediate Similarity NPC103842
0.8429 Intermediate Similarity NPC290803
0.8425 Intermediate Similarity NPC57470
0.8425 Intermediate Similarity NPC473023
0.8421 Intermediate Similarity NPC91105
0.8417 Intermediate Similarity NPC10971
0.8417 Intermediate Similarity NPC37299
0.8417 Intermediate Similarity NPC180261
0.8414 Intermediate Similarity NPC313039
0.8414 Intermediate Similarity NPC473976
0.8414 Intermediate Similarity NPC42540
0.8414 Intermediate Similarity NPC109812
0.8414 Intermediate Similarity NPC198459
0.8414 Intermediate Similarity NPC11700
0.8414 Intermediate Similarity NPC151607
0.8414 Intermediate Similarity NPC131043
0.8409 Intermediate Similarity NPC229649
0.8406 Intermediate Similarity NPC250057
0.8406 Intermediate Similarity NPC324482
0.8403 Intermediate Similarity NPC82913
0.8403 Intermediate Similarity NPC322112
0.8403 Intermediate Similarity NPC55832
0.8403 Intermediate Similarity NPC26051
0.8403 Intermediate Similarity NPC52789
0.8403 Intermediate Similarity NPC268204
0.8403 Intermediate Similarity NPC282300
0.84 Intermediate Similarity NPC471695
0.8394 Intermediate Similarity NPC73203
0.8392 Intermediate Similarity NPC139554
0.8392 Intermediate Similarity NPC64664
0.8392 Intermediate Similarity NPC473209
0.8392 Intermediate Similarity NPC270913
0.8392 Intermediate Similarity NPC217186
0.8392 Intermediate Similarity NPC55018
0.8392 Intermediate Similarity NPC303633
0.8392 Intermediate Similarity NPC23257
0.8392 Intermediate Similarity NPC216978
0.8392 Intermediate Similarity NPC220062
0.8392 Intermediate Similarity NPC472515
0.8392 Intermediate Similarity NPC156872
0.8392 Intermediate Similarity NPC96565
0.8392 Intermediate Similarity NPC53181
0.8392 Intermediate Similarity NPC283429
0.8392 Intermediate Similarity NPC301217
0.8389 Intermediate Similarity NPC312549

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470989 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8489 Intermediate Similarity NPD6651 Approved
0.8483 Intermediate Similarity NPD2534 Approved
0.8483 Intermediate Similarity NPD2533 Approved
0.8483 Intermediate Similarity NPD2532 Approved
0.8451 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8392 Intermediate Similarity NPD2800 Approved
0.8231 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8231 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8158 Intermediate Similarity NPD7819 Suspended
0.8117 Intermediate Similarity NPD7075 Discontinued
0.8105 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8101 Intermediate Similarity NPD7473 Discontinued
0.8026 Intermediate Similarity NPD7411 Suspended
0.7986 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7986 Intermediate Similarity NPD1510 Phase 2
0.7961 Intermediate Similarity NPD4380 Phase 2
0.7959 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7958 Intermediate Similarity NPD1240 Approved
0.7922 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD6232 Discontinued
0.7891 Intermediate Similarity NPD1243 Approved
0.7862 Intermediate Similarity NPD2799 Discontinued
0.7857 Intermediate Similarity NPD6801 Discontinued
0.7847 Intermediate Similarity NPD1607 Approved
0.7838 Intermediate Similarity NPD3750 Approved
0.7821 Intermediate Similarity NPD7768 Phase 2
0.7812 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD5710 Approved
0.7799 Intermediate Similarity NPD5711 Approved
0.7755 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7755 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7703 Intermediate Similarity NPD1549 Phase 2
0.7692 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7687 Intermediate Similarity NPD2935 Discontinued
0.7687 Intermediate Similarity NPD2796 Approved
0.7683 Intermediate Similarity NPD5953 Discontinued
0.7682 Intermediate Similarity NPD6799 Approved
0.7682 Intermediate Similarity NPD7390 Discontinued
0.7658 Intermediate Similarity NPD3749 Approved
0.7647 Intermediate Similarity NPD920 Approved
0.7613 Intermediate Similarity NPD6599 Discontinued
0.76 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD943 Approved
0.758 Intermediate Similarity NPD2801 Approved
0.7569 Intermediate Similarity NPD2313 Discontinued
0.7569 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7566 Intermediate Similarity NPD1511 Approved
0.7561 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7548 Intermediate Similarity NPD3226 Approved
0.7547 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7534 Intermediate Similarity NPD230 Phase 1
0.7533 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7532 Intermediate Similarity NPD3817 Phase 2
0.7516 Intermediate Similarity NPD6959 Discontinued
0.7516 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3748 Approved
0.75 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD1512 Approved
0.7465 Intermediate Similarity NPD1164 Approved
0.7455 Intermediate Similarity NPD7286 Phase 2
0.745 Intermediate Similarity NPD5405 Approved
0.745 Intermediate Similarity NPD5404 Approved
0.745 Intermediate Similarity NPD1551 Phase 2
0.745 Intermediate Similarity NPD5406 Approved
0.745 Intermediate Similarity NPD5408 Approved
0.7415 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7415 Intermediate Similarity NPD5124 Phase 1
0.7405 Intermediate Similarity NPD1934 Approved
0.74 Intermediate Similarity NPD2344 Approved
0.7391 Intermediate Similarity NPD9545 Approved
0.7375 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD3882 Suspended
0.7372 Intermediate Similarity NPD9493 Approved
0.7338 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD6099 Approved
0.7333 Intermediate Similarity NPD6100 Approved
0.7329 Intermediate Similarity NPD3764 Approved
0.7329 Intermediate Similarity NPD3268 Approved
0.7308 Intermediate Similarity NPD5403 Approved
0.7305 Intermediate Similarity NPD422 Phase 1
0.7292 Intermediate Similarity NPD2798 Approved
0.7289 Intermediate Similarity NPD3818 Discontinued
0.7285 Intermediate Similarity NPD2346 Discontinued
0.7278 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7267 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD9717 Approved
0.7246 Intermediate Similarity NPD7054 Approved
0.7239 Intermediate Similarity NPD5494 Approved
0.7222 Intermediate Similarity NPD1203 Approved
0.7222 Intermediate Similarity NPD1470 Approved
0.7222 Intermediate Similarity NPD2797 Approved
0.7208 Intermediate Similarity NPD2309 Approved
0.7205 Intermediate Similarity NPD5402 Approved
0.7202 Intermediate Similarity NPD7074 Phase 3
0.7202 Intermediate Similarity NPD7472 Approved
0.7192 Intermediate Similarity NPD6832 Phase 2
0.7179 Intermediate Similarity NPD5401 Approved
0.7178 Intermediate Similarity NPD919 Approved
0.7176 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6166 Phase 2
0.7143 Intermediate Similarity NPD1465 Phase 2
0.7143 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD4628 Phase 3
0.7133 Intermediate Similarity NPD9269 Phase 2
0.7118 Intermediate Similarity NPD7251 Discontinued
0.7118 Intermediate Similarity NPD6559 Discontinued
0.7107 Intermediate Similarity NPD7458 Discontinued
0.7092 Intermediate Similarity NPD9268 Approved
0.7078 Intermediate Similarity NPD2654 Approved
0.7076 Intermediate Similarity NPD7808 Phase 3
0.7063 Intermediate Similarity NPD1201 Approved
0.7059 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD6797 Phase 2
0.7041 Intermediate Similarity NPD5844 Phase 1
0.7037 Intermediate Similarity NPD74 Approved
0.7037 Intermediate Similarity NPD9266 Approved
0.7019 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7014 Intermediate Similarity NPD1608 Approved
0.7011 Intermediate Similarity NPD8150 Discontinued
0.7006 Intermediate Similarity NPD3926 Phase 2
0.7 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.6986 Remote Similarity NPD3266 Approved
0.6986 Remote Similarity NPD3267 Approved
0.6983 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6981 Remote Similarity NPD6980 Clinical (unspecified phase)
0.698 Remote Similarity NPD4907 Clinical (unspecified phase)
0.698 Remote Similarity NPD1296 Phase 2
0.6963 Remote Similarity NPD9264 Approved
0.6963 Remote Similarity NPD9267 Approved
0.6963 Remote Similarity NPD9263 Approved
0.6963 Remote Similarity NPD9265 Clinical (unspecified phase)
0.6962 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6959 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6954 Remote Similarity NPD447 Suspended
0.6946 Remote Similarity NPD7229 Phase 3
0.6928 Remote Similarity NPD7033 Discontinued
0.6928 Remote Similarity NPD4308 Phase 3
0.6923 Remote Similarity NPD7003 Approved
0.689 Remote Similarity NPD4288 Approved
0.6886 Remote Similarity NPD1247 Approved
0.6882 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6872 Remote Similarity NPD4363 Phase 3
0.6872 Remote Similarity NPD4360 Phase 2
0.6871 Remote Similarity NPD37 Approved
0.6867 Remote Similarity NPD411 Approved
0.6867 Remote Similarity NPD6234 Discontinued
0.6848 Remote Similarity NPD4967 Phase 2
0.6848 Remote Similarity NPD4966 Approved
0.6848 Remote Similarity NPD4965 Approved
0.6846 Remote Similarity NPD4908 Phase 1
0.6845 Remote Similarity NPD8151 Discontinued
0.6839 Remote Similarity NPD8313 Approved
0.6839 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6004 Phase 3
0.6839 Remote Similarity NPD8312 Approved
0.6839 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6839 Remote Similarity NPD6005 Phase 3
0.6839 Remote Similarity NPD6002 Phase 3
0.6836 Remote Similarity NPD4287 Approved
0.6836 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6833 Remote Similarity NPD4362 Clinical (unspecified phase)
0.6833 Remote Similarity NPD4361 Phase 2
0.6824 Remote Similarity NPD6007 Clinical (unspecified phase)
0.6818 Remote Similarity NPD8434 Phase 2
0.6806 Remote Similarity NPD17 Approved
0.6803 Remote Similarity NPD3225 Approved
0.6772 Remote Similarity NPD6190 Approved
0.6765 Remote Similarity NPD2403 Approved
0.6757 Remote Similarity NPD7435 Discontinued
0.6755 Remote Similarity NPD1699 Clinical (unspecified phase)
0.675 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6739 Remote Similarity NPD4750 Phase 3
0.6738 Remote Similarity NPD9281 Approved
0.6735 Remote Similarity NPD4749 Approved
0.6732 Remote Similarity NPD6355 Discontinued
0.672 Remote Similarity NPD8319 Approved
0.672 Remote Similarity NPD8320 Phase 1
0.6716 Remote Similarity NPD846 Approved
0.6716 Remote Similarity NPD940 Approved
0.6712 Remote Similarity NPD1610 Phase 2
0.6709 Remote Similarity NPD8166 Discontinued
0.669 Remote Similarity NPD4626 Approved
0.6689 Remote Similarity NPD1283 Approved
0.6687 Remote Similarity NPD2296 Approved
0.6687 Remote Similarity NPD5808 Clinical (unspecified phase)
0.6687 Remote Similarity NPD5353 Approved
0.6687 Remote Similarity NPD8438 Clinical (unspecified phase)
0.6687 Remote Similarity NPD6143 Clinical (unspecified phase)
0.6686 Remote Similarity NPD7199 Phase 2
0.6686 Remote Similarity NPD7228 Approved
0.6685 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6685 Remote Similarity NPD6535 Approved
0.6685 Remote Similarity NPD6534 Approved
0.6667 Remote Similarity NPD5537 Clinical (unspecified phase)
0.6667 Remote Similarity NPD9261 Approved
0.6667 Remote Similarity NPD3972 Approved
0.6667 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6667 Remote Similarity NPD4307 Phase 2

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data